Claret Medical is a privately-held company focused on innovative solutions for cerebral protection during structural heart interventions, vascular interventions, and cardiac surgery procedures. The company is currently focusing product development and clinical research on addressing the problem of stroke during TAVR, a significant unmet clinical need.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/21/14 | $18,000,000 | Series B |
Easton Capital Lightstone Ventures Sante Ventures | undisclosed |
